Literature DB >> 18335269

Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse model.

Yufeng Li1, Eiko Sugiyama, Shin Yokoyama, Lingling Jiang, Naoki Tanaka, Toshifumi Aoyama.   

Abstract

This study aimed to clarify the molecular mechanisms of age-specific hepatic lipid accumulation accompanying hyperinsulinemia in a peroxisome proliferator-activated receptor alpha (PPARalpha) (+/-):low-density lipoprotein receptor (LDLR) (+/-) mouse line. The hepatic fat content, protein amounts, and mRNA levels of genes involved in hepatic lipid metabolism were analyzed in 25-, 50-, 75- and 100-week-old mice. Severe fatty liver was confirmed only in 50- and 75-week-old mice. The hepatic expression of proteins that function in lipid transport and catabolism did not differ among the groups. In contrast, the mRNA levels and protein amounts of lipogenic enzymes, including acetyl-coenzyme A carboxylase-1, fatty acid synthase, and glycerol-3-phosphate acyltransferase, enhanced in the mice with fatty liver. Elevated mRNA and protein levels of lipoprotein lipase and fatty acid translocase, which are involved in hepatic lipid uptake, were also detected in mice with fatty liver. Moreover, both protein and mRNA levels of sterol regulatory element-binding protein-1 (SREBP-1), a transcription factor regulating lipid synthesis, had age-specific patterns similar to those of the proteins described above. Therefore, the age-specific fatty liver found in the PPARalpha (+/-):LDLR (+/-) mouse line is probably caused by age-specific expression of SREBP-1 and its downstream lipogenic genes, coordinated by the increased uptake of lipids. All of these factors might be affected by age-specific changes in serum insulin concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18335269     DOI: 10.1007/s11745-008-3161-x

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  59 in total

1.  PPARalpha protects proximal tubular cells from acute fatty acid toxicity.

Authors:  Yuji Kamijo; Kazuhiko Hora; Keiichi Kono; Kyoko Takahashi; Makoto Higuchi; Takashi Ehara; Kendo Kiyosawa; Hidekazu Shigematsu; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

2.  Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training.

Authors:  Motoyuki Iemitsu; Takashi Miyauchi; Seiji Maeda; Takumi Tanabe; Masakatsu Takanashi; Yoko Irukayama-Tomobe; Satoshi Sakai; Hajime Ohmori; Mitsuo Matsuda; Iwao Yamaguchi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

3.  Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.

Authors:  Eric S Goetzman; Liqun Tian; Philip A Wood
Journal:  Mol Genet Metab       Date:  2004-11-11       Impact factor: 4.797

Review 4.  Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver.

Authors:  H Shimano
Journal:  Trends Cardiovasc Med       Date:  2000-10       Impact factor: 6.677

5.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha.

Authors:  Elena Sanguino; Miguel Ramón; Liliane Michalik; Walter Wahli; Marta Alegret; Rosa M Sánchez; Manuel Vázquez-Carrera; Juan C Laguna
Journal:  Biochem Pharmacol       Date:  2004-01-01       Impact factor: 5.858

7.  A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.

Authors:  T Aoyama; Y Uchida; R I Kelley; M Marble; K Hofman; J H Tonsgard; W J Rhead; T Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

8.  Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

Authors:  K Motojima; P Passilly; J M Peters; F J Gonzalez; N Latruffe
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements.

Authors:  Lauren M Cagen; Xiong Deng; Henry G Wilcox; Edwards A Park; Rajendra Raghow; Marshall B Elam
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

View more
  2 in total

1.  Advanced glycation endproduct changes to Bruch's membrane promotes lipoprotein retention by lipoprotein lipase.

Authors:  Marisol Cano; Natalia Fijalkowski; Naoshi Kondo; Sonny Dike; James Handa
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

2.  Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.

Authors:  Takero Nakajima; Naoki Tanaka; Hiroki Kanbe; Atsushi Hara; Yuji Kamijo; Xiaowei Zhang; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Mol Pharmacol       Date:  2009-01-05       Impact factor: 4.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.